Collagen- versus gelatine-coated Dacron versus stretch PTFE bifurcation grafts for aortoiliac occlusive disease:: Long-term results of a prospective, randomized multicenter trial

被引:39
作者
Prager, MR
Hoblaj, T
Nanobashvili, J
Sporn, E
Polterauer, P
Wagner, O
Böhmig, HJ
Teufelsbauer, H
Ploner, M
Huk, I
机构
[1] Univ Vienna, Sch Med, Dept Vasc Surg, AKH, A-1090 Vienna, Austria
[2] Ludwig Boltzmann Res Inst Interdisciplinary Vasc, Vienna, Austria
关键词
D O I
10.1067/msy.2003.179
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. In this prospective randomized multicenter trial, knitted gelatine-coated Dacron, knitted collagen-coated Dacron, and stretch poly tetrafluoroethylene (PTFE) aortic bifurcation grafts were compared for their long-term results. Methods. Between 1991 and 1998, 149 patients undergoing elective revascularization for aortoiliac occlusive disease were prospectively randomized at 3 tertiary referral centers of vascular surgery. The patients received either gelatine-coated Dacron (GEL-D) grafts (n = 52), collagen-coated Dacron (COLD) grafts (n = 49), or stretch PTFE grafts (n = 48). Results. No intraoperative deaths were recorded. The 30-day mortality was 4%. The mean follow-up time was 97 months. Primary patency rates were 77% for GEL-D, 78% for COL-D, and 79% for PTFE at 8 years. The differences were not different (P > .8). Secondary corrected 8-year patency rates were also not significantly different (P > .5): 91% for GEL-D, 96% for COL-Dm and 90% for PTFE. Five Dacron and 1 PTFE grafts were affected by infections. Conclusions. Bifurcation grafts for revascularization of aortoiliac occlusive disease using these 3 materials were comparable in terms. of primary and secondary patency and long-term complication rates.
引用
收藏
页码:80 / 85
页数:6
相关论文
共 29 条
[11]  
GOEAUBRISSONIER.O, 1990, ANEURYSMES LAORTE AB, P143
[12]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[13]  
KARNER J, 1987, ACTA CHIR AUSTRIACA, V1, P8
[14]  
KRAM H, 1990, CAUSE MANAGEMENT ANE, P340
[15]  
Lord R S, 1988, Ann Vasc Surg, V2, P248, DOI 10.1016/S0890-5096(07)60010-7
[16]   SEQUENTIAL TREATMENT ASSIGNMENT WITH BALANCING FOR PROGNOSTIC FACTORS IN CONTROLLED CLINICAL TRIAL [J].
POCOCK, SJ ;
SIMON, R .
BIOMETRICS, 1975, 31 (01) :103-115
[17]   THE PTFE Y-GRAFT - ONE YEAR EXPERIENCE IN 21 PATIENTS - A PRELIMINARY-REPORT [J].
POLTERAUER, P ;
WAGNER, O ;
KRETSCHMER, G ;
PIZA, F .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1982, 5 (04) :263-266
[18]  
POLTERAUER P, 1984, CHIRURG, V55, P106
[19]  
POLTERAUER P, 1992, SURGERY, V111, P626
[20]  
POLTERAUER P, 1982, VASCULAR SURG, V14, P390